These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1383888)

  • 21. Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus.
    Moncada C; Arvin B; Le Peillet E; Meldrum BS
    Neurosci Lett; 1991 Dec; 133(2):287-90. PubMed ID: 1816508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cyclooxygenase-2 mRNA after global ischemia is regulated by AMPA receptors and glucocorticoids.
    Koistinaho J; Koponen S; Chan PH
    Stroke; 1999 Sep; 30(9):1900-5; discussion 1905-6. PubMed ID: 10471443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
    Willis CL; Meldrum BS; Nunn PB; Anderton BH; Leigh PN
    Brain Res; 1993 Nov; 627(1):55-62. PubMed ID: 7507397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Over-additive protective effect of dizocilpine and NBQX against neuronal damage.
    Lippert K; Welsch M; Krieglstein J
    Eur J Pharmacol; 1994 Mar; 253(3):207-13. PubMed ID: 7911083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the metabotropic glutamate receptor in mouse cerebellar granule cells: lack of effect of 2,3-dihydroxy-6-nitro-7-sulphamoylbenzo(F)-quinoxaline (NBQX).
    Suzdak PD; Sheardown MJ; Honoré T
    Eur J Pharmacol; 1993 May; 245(3):215-20. PubMed ID: 7687559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of NBQX on the distal and local toxicity of glutamate agonists administered intra-hippocampally.
    Lees GJ; Leong W
    Brain Res; 1993 Nov; 628(1-2):1-7. PubMed ID: 7508807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The AMPA antagonist NBQX protects thalamic reticular neurons from degeneration following cardiac arrest in rats.
    Ross DT; Brasko J; Patrikios P
    Brain Res; 1995 Jun; 683(1):117-28. PubMed ID: 7552336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complex pharmacological properties of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subtypes.
    Stein E; Cox JA; Seeburg PH; Verdoorn TA
    Mol Pharmacol; 1992 Nov; 42(5):864-71. PubMed ID: 1279377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats.
    Buchan AM; Li H; Cho S; Pulsinelli WA
    Neurosci Lett; 1991 Nov; 132(2):255-8. PubMed ID: 1664505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiological evidence for the existence of NMDA and non-NMDA receptors on rat ventral tegmental dopamine neurons.
    Wang T; French ED
    Synapse; 1993 Mar; 13(3):270-7. PubMed ID: 7684531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655.
    Palmer AJ; Lodge D
    Eur J Pharmacol; 1993 Jan; 244(2):193-4. PubMed ID: 7679352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The AMPA receptor antagonist NBQX does not alter the motor response induced by selective dopamine agonists in MPTP-treated monkeys.
    Luquin MR; Obeso JA; Laguna J; Guillén J; Martínez-Lage JM
    Eur J Pharmacol; 1993 Apr; 235(2-3):297-300. PubMed ID: 7685291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional variations in the pharmacology of AMPA receptors as revealed by receptor autoradiography.
    Porter RH; Greenamyre JT
    Brain Res; 1994 Nov; 664(1-2):202-6. PubMed ID: 7534602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model.
    Gill R; Nordholm L; Lodge D
    Brain Res; 1992 May; 580(1-2):35-43. PubMed ID: 1504814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excitotoxic effects of non-NMDA receptor agonists in organotypic corticostriatal slice cultures.
    Kristensen BW; Noraberg J; Jakobsen B; Gramsbergen JB; Ebert B; Zimmer J
    Brain Res; 1999 Sep; 841(1-2):143-59. PubMed ID: 10546997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia.
    Minger SL; Geddes JW; Holtz ML; Craddock SD; Whiteheart SW; Siman RG; Pettigrew LC
    Brain Res; 1998 Nov; 810(1-2):181-99. PubMed ID: 9813316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excitatory amino acid receptors and ischemic brain damage in the rat.
    Westerberg E; Monaghan DT; Cotman CW; Wieloch T
    Neurosci Lett; 1987 Jan; 73(2):119-24. PubMed ID: 2881232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-tracer autoradiographic study of protein synthesis and glucose consumption in rats with focal cerebral ischemia.
    Christensen T; Balchen T; Bruhn T; Diemer NH
    Neurol Res; 1999 Oct; 21(7):687-94. PubMed ID: 10555193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional changes of N-methyl-D-aspartic acid and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate channels in gerbil hippocampal CA1, in relation to postischemic enhancement of glutamate receptor-mediated responses.
    Ikemune K; Mitani A; Namba S; Kataoka K; Arai T
    Neurosci Lett; 1999 Nov; 275(2):125-8. PubMed ID: 10568515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postischaemic changes in protein synthesis in the rat brain: effects of hypothermia.
    Bergstedt K; Hu BR; Wieloch T
    Exp Brain Res; 1993; 95(1):91-9. PubMed ID: 8405256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.